Target intelligence / Profile preview

Spike Glycoprotein of SARS-like Coronavirus (CoV_S1)

Target
CoV_S1
Molecular classification
Viral protein, Glycoprotein, Fusion protein, Type I transmembrane protein
01

Overview

The spike (S) glycoprotein is a large, trimeric transmembrane protein found on the surface of SARS-like coronaviruses, including SARS-CoV and SARS-CoV-2. It is the most prominent structural protein and mediates viral entry into host cells by binding to specific cell surface receptors and facilitating membrane fusion. The S glycoprotein assembles as a homotrimer protruding from the viral envelope. Each monomer consists of two main functional subunits: S1 (containing the NTD and RBD, responsible for receptor binding) and S2 (containing elements required for membrane fusion). A furin cleavage site between S1 and S2 allows host proteases to activate the protein. The S glycoprotein is highly immunogenic and a major target of neutralizing antibodies and vaccines. Mutations in the spike protein can affect infectivity, antibody recognition, and vaccine efficacy.

Other names
SARS-CoV Spike proteinSARS-CoV-2 Spike proteinS glycoproteinSpike protein
02

Mechanism of action

Blockage of receptor binding, inhibition of membrane fusion

03

Biological functions

Viral entryHost cell attachmentMembrane fusionReceptor binding (ACE2)Immune evasion
04

Disease associations

InfectionCOVID-19 pathogenesisSARS pathogenesis
05

Safety considerations

Antibody-dependent enhancement (ADE)Escape mutationsOff-target effects of therapeuticsPotential for immune evasion
06

Interacting drugs

Neutralizing antibodies

2 more in the full profile.

07

Biomarkers

Spike protein levelsAnti-Spike antibody titers

Beyond the preview

Go deeper on Spike Glycoprotein of SARS-like Coronavirus (CoV_S1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spike Glycoprotein of SARS-like Coronavirus (CoV_S1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call